CHINA PHARMACEUTICALS INC Accounts Receivable, Credit Loss Expense (Reversal)
CHINA PHARMACEUTICALS INC reported Accounts Receivable, Credit Loss Expense (Reversal) of $474.07 thousand for the 3-month period ending 2012-06-30, per its 10-Q/A filed 2012-08-27.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProvisionForDoubtfulAccounts · last filed 2012-08-27
- CHINA PHARMACEUTICALS INC accounts receivable, credit loss expense (reversal) for the quarter ending 2012-06-30 was $474.07K.
- CHINA PHARMACEUTICALS INC accounts receivable, credit loss expense (reversal) for the quarter ending 2012-03-31 was -$44.99K.
- CHINA PHARMACEUTICALS INC accounts receivable, credit loss expense (reversal) for the quarter ending 2011-12-31 was $314.98K, a 68.27% decline year-over-year.
- CHINA PHARMACEUTICALS INC accounts receivable, credit loss expense (reversal) for the quarter ending 2011-09-30 was -$18.16K.
- CHINA PHARMACEUTICALS INC accounts receivable, credit loss expense (reversal) for fiscal 2011 was -$267.80K, a 146.21% decline from fiscal 2010.
- CHINA PHARMACEUTICALS INC accounts receivable, credit loss expense (reversal) for fiscal 2010 was $579.51K.
| Period end | Accounts Receivable, Credit Loss Expense (Reversal) 3 month | Accounts Receivable, Credit Loss Expense (Reversal) 6 month | Accounts Receivable, Credit Loss Expense (Reversal) 9 month | Accounts Receivable, Credit Loss Expense (Reversal) 12 month |
|---|---|---|---|---|
| 2012-06-30 | $474.07K 10-Q/A · filed 2012-08-27 | $429.07K 10-Q/A · filed 2012-08-27 | $744.05K derived: sum of 3 quarters · filed 2012-08-27 | $725.89K derived: sum of 4 quarters · filed 2012-08-27 |
| 2012-03-31 | -$44.99K 10-Q · filed 2012-05-21 | $269.98K derived: sum of 2 quarters · filed 2012-05-21 | $251.82K derived: sum of 3 quarters · filed 2012-05-21 | -$32.29K derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-12-31 | $314.98K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | $296.81K derived: sum of 2 quarters · filed 2012-05-07 | $12.70K derived: sum of 3 quarters · filed 2012-08-27 | -$267.80K 10-K · filed 2012-05-07 |
| 2011-09-30 | -$18.16K 10-Q · filed 2011-11-21 | -$302.28K derived: sum of 2 quarters · filed 2012-08-27 | -$582.78K 10-Q · filed 2011-11-21 | $409.79K derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-06-30 | -$284.11K 10-Q/A · filed 2012-08-27 | -$564.62K 10-Q/A · filed 2012-08-27 | $427.96K derived: sum of 3 quarters · filed 2012-08-27 | -$186.05K derived: sum of 4 quarters · filed 2012-08-27 |
| 2011-03-31 | -$280.50K 10-Q · filed 2012-05-21 | $712.07K derived: sum of 2 quarters · filed 2012-05-21 | $98.06K derived: sum of 3 quarters · filed 2012-05-21 | -$2.24M derived: sum of 4 quarters · filed 2012-05-21 |
| 2010-12-31 | $992.57K derived: 10-K 12 month − 10-Q 9 month · filed 2012-05-07 | $378.56K derived: sum of 2 quarters · filed 2012-05-07 | -$1.96M derived: sum of 3 quarters · filed 2012-05-07 | $579.51K 10-K · filed 2012-05-07 |
| 2010-09-30 | -$614.01K 10-Q · filed 2011-11-21 | -$2.95M derived: sum of 2 quarters · filed 2011-11-21 | -$413.06K 10-Q · filed 2011-11-21 | |
| 2010-06-30 | -$2.33M 10-Q/A · filed 2011-09-16 | $200.95K 10-Q/A · filed 2012-06-20 |